Short answer
Align Technology (ALGN) filed an 8-K current report with the SEC on November 18, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item EX-99.1 (Exhibit EX-99.1). Board expands from 11 to 13 directors, adding Paul Clancy immediately and Ian Bell effective December 10, 2026.
Align Technology 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Board expands from 11 to 13 directors, adding Paul Clancy immediately and Ian Bell effective December 10, 2026
- Both nominees expected to stand for shareholder election at the May 2027 annual meeting
- Prorated non-employee director retainers and equity grants create incremental governance-related compensation costs
- No disclosed related-party transactions or selection arrangements, reducing immediate conflict-of-interest concerns
Item EX-99.1 · Exhibit EX-99.1
- Paul J. Clancy appointed director immediately, adding former Alexion and Biogen CFO expertise
- Ian Bell joins December 10, 2026, bringing Alcon commercial, manufacturing, quality and regulatory experience
- Board expands to 13 directors, then declines to 12 after C. Raymond Larkin Jr.’s December 31 retirement
- Both nominees will stand for shareholder election at Align’s 2027 annual meeting
- Appointments strengthen financial oversight and healthcare operating expertise as Align pursues long-term growth strategy
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Align Technology 8-K filings
Get the next ALGN 8-K as it lands
Follow ALGN for push alerts, or ask the research agent what this filing means.